Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CZECH-ICIT: Immunosuppression in Inflammatory Cardiomyopathy
NCT01877746Phase 3Unknown
- Sponsor
- St. Anne's University Hospital Brno
- Start
- Jan 2013
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of prednisone and azathioprine in inflammatory cardiomyopathy (3 arms), sponsored by St. Anne's University Hospital Brno. Primary endpoint: Change in Left Ventricular Ejection Fraction at 12 months. Status: unknown.
02
Drugs
prednisoneazathioprine
03
Conditions
inflammatory cardiomyopathy
Beyond the preview
Go deeper on NCT01877746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01877746.